These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21637067)

  • 1. Cutaneous sarcoidosis evaluated by FDG PET.
    Li Y; Berenji GR
    Clin Nucl Med; 2011 Jul; 36(7):584-6. PubMed ID: 21637067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
    Lu SJ; Lee VK; Loo SW
    Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Be aware of disseminated sarcoidosis with diffuse subcutaneous nodules on F-18 FDG PET.
    Rafiei P; Vijayakumar V
    Clin Nucl Med; 2011 Jun; 36(6):e42-4. PubMed ID: 21552015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal sarcoidosis detected by FDG positron emission tomography.
    Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
    Clin Nucl Med; 2008 Dec; 33(12):878-9. PubMed ID: 19033796
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Bompard F; de Menthon M; Gomez L; Gottlieb J; Saleh NS; Chekroun M; Grimon G; Goujard C; Durand E; Besson FL
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1980-1981. PubMed ID: 31123764
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffuse renal (18)F-FDG uptake of a patient with fever of unknown origin revealed sarcoidosis.
    Toyonaga T; Manabe O; Gaertner FC; Nakagaki T; Nishio S; Suzuki A; Tamaki N
    Clin Nucl Med; 2014 Jul; 39(7):648-9. PubMed ID: 24873783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
    Iino M; Iizuka C
    Rinsho Ketsueki; 2012 May; 53(5):540-2. PubMed ID: 22728558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of fluorodeoxyglucose-positron emission tomography in a case of pleural sarcoidosis].
    Hattori T; Konno S; Inomata T; Nasuhara Y; Betsuyaku T; Nishimura M
    Nihon Kokyuki Gakkai Zasshi; 2009 Jul; 47(7):658-62. PubMed ID: 19637812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
    Aide N; Benayoun M; Kerrou K; Khalil A; Cadranel J; Talbot JN
    Br J Radiol; 2007 Mar; 80(951):e67-71. PubMed ID: 17548505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic change in 18F-FDG uptake in a sarcoidosis case showing spontaneous recovery.
    Ito K; Miyata Y; Minamimoto R; Kubota K
    Clin Nucl Med; 2014 Apr; 39(4):376-8. PubMed ID: 23640228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
    Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
    Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT findings in acquired perforating dermatosis.
    Shinmura A; Abe K; Baba S; Isoda T; Maruoka Y; Yasukawa F; Kiryu H; Sasaki M; Furue M; Honda H
    Clin Nucl Med; 2012 Oct; 37(10):997-1000. PubMed ID: 22955075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
    Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ
    Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Onset of Sarcoidosis After COVID-19 Vaccination Revealed by the 18 F-FDG PET.
    Song X; Shao F; Lan X
    Clin Nucl Med; 2022 Oct; 47(10):869-871. PubMed ID: 35867999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT imaging of extensive systemic sarcoidosis with epididymal involvement.
    Aga F; Yamamoto Y; Tanaka K; Ono Y; Dobashi H; Nishiyama Y
    Clin Nucl Med; 2013 Jan; 38(1):63-4. PubMed ID: 23242053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
    Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V
    J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular sarcoidosis: does (18)F-FDG PET/CT have any role?
    Jung RS; Mittal BR; Maturu NV; Kumar R; Bhattacharya A; Gupta D
    Clin Nucl Med; 2014 May; 39(5):464-6. PubMed ID: 24662648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An atypical sarcoidosis involvement in FDG PET/CT: A case report.
    Robin P; Benigni P; Feger B; Salaun PY; Abgral R
    Medicine (Baltimore); 2016 Dec; 95(52):e5700. PubMed ID: 28033265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study.
    Ambrosini V; Zompatori M; Fasano L; Nanni C; Nava S; Rubello D; Fanti S
    Clin Nucl Med; 2013 Apr; 38(4):e171-7. PubMed ID: 23429384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic involvement detected with (18)F-FDG PET/CT in disseminated sarcoidosis.
    Delgado-Bolton RC; Arias Navalón JA; Rodríguez Alfonso B; Delgado-Bolton AN; Pérez-Castejón MJ; Sánchez-Escribano R; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
    Rev Esp Med Nucl; 2011; 30(1):29-32. PubMed ID: 20638156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.